Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: DD™ who wrote (2154)	5/15/1998 11:12:00 AM
From: R. M. Rosenthal	Read Replies (2) \| Respond to of 5736

Res Ipsa from Yahoo: >> Message 1301 of 1302 Reply hepatitis application bglas19 May 15 1998 9:37AM EDT As a medical laboratory worker (Medical Technologist) I have an interest in the device in question. There is no doubt that any non invasive bilirubin diagnostic will have a very good market in the infant bilirubin area. I am the guy who has had to collect the blood sample from the 3 pound premi 3 times a day, while the mom crys and the dad wants to hit me. But my real question is has anyone looked at the potential for this device in monitoring bilirubin levels in hepatic diseases, especially viral hepatitis. CDC #'s cdc.gov for the USA show over 7 million cases of Hepatitis A-E each year. These lead to over 5 million ongoing chronic infections which ultimatly lead to chronic liver disease. Bilirubin monitoring is routine in all cases of suspected or diagnosed liver disease, with multiple testing over several weeks or months as the usual procedure. (increasing Bilirubin levels indicating increased liver damage) I don't have a total number of bilirubin test performed each year in the US, but the number associated with infants is only a part of the total. While the US numbers are big, the incidence of Viral Hepatitis in the US is very low compared to the rest of the world. Also, a reusable, non invasive device, which can be used at the doctors office, or by goverment health workers in the field, will be well accepted in developing countries where there are severe shortages of even the most basic laboratory services. (I know, I've been there in Brasil, Paraguay, Uruguay, Bolivia, South Afica, etc) I don't know what the final numbers will be, or if, or when a distrubution deal will happen. But, if this thing works (and FDA says it does) I have no doubt about the market potential, and some big players will want a piece of the action.<<